London-based life science investor Syncona today announced its interim results for the six months ending 30 September 2024.

Assura announced pre-tax profit of £77.1 million for the six months ending 30 September 2024, compared to a net loss of £17.8 million reported for the same period last year.

Healthcare M&A has rebounded in a big way. Year-end figures should see at least £2.5bn worth of transactions completed in the UK. Elderly care has proved particularly attractive.